The world keeps turning: WHO’s 140th Executive Board meeting begins
With the 140th World Health Organization (WHO) Executive Board meeting commencing this week, GHTC takes a look at what's on the agenda and how it could impact global health R&D.
Sign up to receive news and updates from GHTC.
Policy and Advocacy Officer
Total of 22 blog posts
With the 140th World Health Organization (WHO) Executive Board meeting commencing this week, GHTC takes a look at what's on the agenda and how it could impact global health R&D.
An essential diagnostic list list in a smart, cost-effective idea that could advance diagnostic R&D and access.
The 71st United Nations General Assembly (UNGA) concluded this week. Breakthroughs gives a synopsis of the key global health R&D issues discussed at the assembly and what actions were taken.
At the United Nations General Assembly, world leaders made an unprecedented collective commitment to fighting the growing problem of antimicrobial resistance. GHTC and Global Health Council analyze what that commitment entails, why it matters, and the importance of what happens next.
The midtown Manhattan mayhem begins with the opening of the 71st United Nations General Assembly. GHTC preview the global health policy issues that will be discussed at this year's assembly.
As happens every May, the World Health Organization’s (WHO) highest governing body, the World Health Assembly (WHA), met last week for its 69th annual meeting in Geneva, Switzerland. The agenda was the most packed in recent memory, consisting of more than 70 discussion items, many of which were controversial. Despite the lengthy agenda and difficult conversations, the WHA made two key decisions impacting global health research and development (R&D).